EMA hesitates over flunking Curevac vaccine despite missed target

The European Medicines Agency is reluctant to implement the 50 percent efficacy threshold for covid-19 vaccines.

Photo: Yves Herman/REUTERS / X00380

On Thursday, the European Medicines Agency (EMA) reported that it will not be implementing a 50 percent efficacy threshold for covid-19 vaccines.

On Wednesday, it emerged that the Curevac vaccine has 47 percent efficacy. It therefore does not live up to statistical success criteria.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs